Big Stories

Safe-T Group

For Safe-T Group Ltd. Stock, Consolidation Can Be The Pause Needed To Refuel Its Bullish Run ($SFET)

Safe-T Group Ltd. (NASDAQ, TASE: SFET) stock is taking a consolidation breather after ramping higher by over 11% to start the new year. But that pause may be short-lived. After all, SFET enters 2023 with considerable revenue-generating momentum at its back. In fact, the time may be ripe for trading ahead of Q4 numbers knowing

For Safe-T Group Ltd. Stock, Consolidation Can Be The Pause Needed To Refuel Its Bullish Run ($SFET) Read More »

Avalon GloboCare

Safe-T Group Ltd. Shares Jump 8% On News That Wholly Owned NetNut Subsidiary Expands Market Reach ($SFET)

Safe-T Group Ltd. (NASDAQ, TASE: SFET) keeps getting bigger, and its stock responded in kind by jumping 8% on Monday. The bullish move gained momentum in the new year, after $SFET announced that its wholly owned subsidiary and enterprise privacy network unit, NetNut, is expanding its presence into the price comparison market, intending to accelerate

Safe-T Group Ltd. Shares Jump 8% On News That Wholly Owned NetNut Subsidiary Expands Market Reach ($SFET) Read More »

Safe-T Group

Safe-T Group Ltd. Stock Turns Bullish As Record-Setting Revenues Draw Investor Interest ($SFET)

Safe-T Group Ltd. (NASDAQ, TASE: SFET) stock is turning bullish, with investors hanging around into the last week of 2022 scooping up shares of this innovative and global provider of cyber-security and privacy solutions to consumers and enterprises. Currently, SFET stock is higher by about 7% compared to the lows set last week. And based

Safe-T Group Ltd. Stock Turns Bullish As Record-Setting Revenues Draw Investor Interest ($SFET) Read More »

Clearmind Medicine

Clearmind Medicine Inc. Is Blazing A Trail For Psychedelic-Based Treatment For AUD ($CMND)

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) is blazing an innovative trail, positioning to deliver a first-to-market psychedelic-based treatment targeting Alcohol Use Disorder (AUD). That proposition just got stronger. Last week, CMND announced earning yet another patent from the United States Patent and Trademark Office (USPTO), this one protecting its proprietary MEAI as an alcoholic

Clearmind Medicine Inc. Is Blazing A Trail For Psychedelic-Based Treatment For AUD ($CMND) Read More »

Clearmind Medicine

Clearmind Medicine Inc. Shares Surge After Reaching Key Milestones Expediting Marketing Of Psychedelic-Based Treatments($CMND)

The times are changing, and so are the ways chronic conditions can be treated. The relentless lineup of side-effect-laden pharmaceuticals is no longer the only therapeutic option when treating debilitating physical and mental disorders. Better, safer, and more manageable ways of treatment are emerging, disrupting the pharmaceutical landscape and exposing investment opportunities in companies intent

Clearmind Medicine Inc. Shares Surge After Reaching Key Milestones Expediting Marketing Of Psychedelic-Based Treatments($CMND) Read More »

AppTech Payments

AppTech Payments Corp Shares Are Skyrocketing Up 88% In December Here’s Why ($APCX)

AppTech Payments Corp. (NASDAQ: APCX) stock is on fire. On Thursday, APCX stock soared about 41%, adding to its week long rally. Shares are currently trading at $1.66, 88% higher from where they started the month.The leading contributor is that AppTech has positioned itself well to stake its claim as one of the most innovative

AppTech Payments Corp Shares Are Skyrocketing Up 88% In December Here’s Why ($APCX) Read More »

Avalon GloboCare

Avalon GloboCare Strengthens Balance Sheet After $4.0 Million Private Placement Priced At A Premium ($ALBT)

Shares of Avalon GloboCare (NASDAQ: ALBT) have been trending higher. Since December 12th, ALBT stock is over 40% higher, with shares trading today at roughly $0.45 on Friday. News from Avalon last Wednesday provided a solid reason for the bullish sentiment, showing that ALBT’s intention of becoming a more prominent company is happening faster than

Avalon GloboCare Strengthens Balance Sheet After $4.0 Million Private Placement Priced At A Premium ($ALBT) Read More »

Kaival Brands

Kaival Brands Is Positioned For A Massive 2023 Breakout, Here’s Why ($KAVL)

Kaival Brands International (NASDAQ: KAVL) stock may be volatile in December, but make no mistake, they are one of the last electronic nicotine device system (ENDS) sector companies standing in a sector worth potentially billions in revenues. That results from KAVL earning a stay of order from a U.S. District Court that allows KAVL the

Kaival Brands Is Positioned For A Massive 2023 Breakout, Here’s Why ($KAVL) Read More »

Mainz Biomed

Kaival Brands Stock Attractive; Partnerships, Court Wins, And Bidi Vapor Drives Interest ($KAVL)

Kaival Brands International (NASDAQ: KAVL) is on a roll. And a series of updates shows that its business momentum is far from slowing. In fact, quite the opposite. KAVL stock is higher by over 40% YTD, they have inked a major partnership with tobacco industry giant Philip Morris (NYSE: PM), earned a stay of order

Kaival Brands Stock Attractive; Partnerships, Court Wins, And Bidi Vapor Drives Interest ($KAVL) Read More »

AppTech Payments Corp Soars In Q4 Ahead Of Commerse™ Platform Launch ($APCX)

AppTech Payments Corp. (NASDAQ: APCX) stock is soaring. But, despite shares surging over 31% since October, recent updates suggest that plenty more upside growth could still be in play. That’s not an overzealous assumption, either. Recent trading indicates that investors are indeed taking notice of APCX. And with AppTech positioning as one of the most

AppTech Payments Corp Soars In Q4 Ahead Of Commerse™ Platform Launch ($APCX) Read More »